Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Italian Stock Exchange  >  DiaSorin SpA    DIA   IT0003492391

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Italian Stock Exchange
03/20/2017 03/21/2017 03/22/2017 03/23/2017 03/24/2017 Date
62.25(c) 61.95(c) 62.15(c) 63(c) 62.85 Last
168 323 112 926 94 164 83 517 93 970 Volume
+1.47% -0.48% +0.32% +1.37% -0.24% Change
More quotes
Financials (€)
Sales 2017 642 M
EBIT 2017 198 M
Net income 2017 133 M
Finance 2017 174 M
Yield 2017 1,35%
Sales 2018 688 M
EBIT 2018 216 M
Net income 2018 146 M
Finance 2018 274 M
Yield 2018 1,48%
P/E ratio 2017 26,17
P/E ratio 2018 23,80
EV / Sales2017 5,21x
EV / Sales2018 4,72x
Capitalization 3 516 M
More Financials
Company
DiaSorin SpA engages in the development, production, and marketing of reagent kits for in vitro diagnostics.Its business segments are the geographic locations in which it operates: Italy and the United Kingdom; Europe which comprises Germany, France, Belgium, the Netherlands, Spain, Portugal,... 
More about the company
Surperformance© ratings of DiaSorin SpA
Trading Rating : Investor Rating :
More Ratings
Latest news on DIASORIN SPA
02/28 DIASORIN : $25,567 Federal Contract Awarded to DiaSorin
02/23 DIASORIN : reagents and consumables for the production of Liaison analyzers Dias..
2016 DIASORIN : Discover Advances in Parathyroid Hormone Testing in DiaSorin Webinar
2016 DIASORIN : Discover the Clinical Significance of 1,25-Dihydroxyvitamin D Testing..
2016 DIASORIN LAUNCHES ITS FIRST MOLECULA : The new simplexa c. difficile direct mole..
2016 DIASORIN : acquisition of DiaSorin and Alere brand materials
2016 DIASORIN : Webinar Showcases Advances in the Diagnosis of Primary Aldosteronism
2016 ROCHE : Automatic Chemiluminescence Immunoassay Analyzer Market 2016 - Roche, Di..
2016 DIASORIN : Reagents, controls and consumables for automatic immunoassay analyzer..
2016 DIASORIN : Webinar Details Parathyroid Hormone Testing in Chronic Kidney Disease..
More news
Sector news : Diagnostic & Testing Substances
03/22DJMEDTRONIC : Files 8K - Other Events
03/17DJMEDTRONIC : Less-Invasive Treatment Yielded Similar Outcome as Open-Heart Surger..
03/11DJLUXOTTICA : Smart Glasses Get a Fresh Look -- WSJ
03/09DJLUXOTTICA : Eyewear Makers Take a Fresh Look at Smart Glasses
03/09DJLUXOTTICA : Eyewear Makers Rethink Smart Glasses
More sector news : Diagnostic & Testing Substances
Latest Tweets
2016DiaSorin, accordo con Beckman Coulter.
1
2016BRIEF-U.S. HHS awards $2.6 mln to Diasorin group to develop Zika test  
2016Diasorin, downgrade di Morgan Stanley (SoldiOnline.it)  
2016$DGX, $DGX DiaSorin To Acquire Focus Diagnostics' Business From Quest Diagnos..
1
2016DiaSorin buys Quest's diagnostic products business for $300M
1
More tweets
Qtime:3
News from SeekingAlpha
2016 Winner And Losers Among Italian Companies
2016 Diasorin SPA ADR 2016 Q3 - Results - Earnings Call Slides
2016 DiaSorin buys Quest's diagnostic products business for $300M
Advertisement
Chart DIASORIN SPA
Duration : Period :
DiaSorin SpA Technical Analysis Chart | DIA | IT0003492391 | 4-Traders
Full-screen chart
Technical analysis trends DIASORIN SPA
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 10
Average target price 60,7 €
Spread / Average Target -3,4%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Carlo Rosa Chief Executive Officer, Executive Director & GM
Gustavo Denegri Chairman
Piergiorgio Pedron Chief Financial Officer & Senior Corporate VP
Francesco Colotta Chief Medical Officer & Senior Corporate VP
Chen Menachem Even Executive Director & SVP-Commercial Operations
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
DIASORIN SPA12.00%3 796
BIOMERIEUX4.79%6 587
SICHUAN MACCURA BIOTEC..--.--%1 883
SHANGHAI KEHUA BIO-ENG..--.--%1 562
MEDICALSYSTEM BIOTECHN..--.--%1 424
SIEGFRIED HOLDING AG16.90%1 049
More Results